Reappraisal of probiotics’ safety in human

Food and Chemical Toxicology

Volumn 129, Issue , 2019, Pages 22-29

  Sotoudegan, Farzaneh ^a   Daniali, Marzieh ^b,c   Hassani, Shokoufeh ^b,c   Nikfar, Shekoufeh ^c,d   Abdollahi, Mohammad ^b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adverse effects; Probiotics; Risk of toxicity; Safety

Indexed keywords

PROBIOTIC AGENT;

ADVERSE EVENT; BACTEREMIA; CANCER PATIENT; CONSUMER; CRITICALLY ILL PATIENT; ENDOCARDITIS; FUNGEMIA; GASTROINTESTINAL SYMPTOM; GENE TRANSFER; GERIATRIC PATIENT; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; INFECTION; LACTIC ACIDOSIS; MICROFLORA; NONHUMAN; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHYDRATION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SAFETY; SKIN DISEASE; ULTRAVIOLET RADIATION; ADVERSE DRUG REACTION; PATIENT SAFETY;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; PATIENT SAFETY; PROBIOTICS;

EID: 85064613354     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2019.04.032     Document Type: Review

References (110)

1. Apple-da-Silva, M.C., Narvaez, G.A., Perez, L.R.R., Drehmer, L., Lewgoy, J., Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Med Mycol Case Rep 18 (2017), 15–17.
2. Araujo, G.V.d., Oliveira Junior, M.H.d., Peixoto, D.M., Sarinho, E.S.C., Probiotics for the treatment of upper and lower respiratory-tract infections in children: systematic review based on randomized clinical trials. J. Pediatr. 91 (2015), 413–427.
3. Basco, W., Probiotics Work for Kids with AGE, Right? Not So Fast! Medscape. 2019.
4. Besselink, M., van Santvoort, H., Buskens, E., Boermeester, M., van Goor, H., Timmerman, H., Nieuwenhuijs, V., Bollen, T., van Ramshorst, B., Witteman, B., Probiotic prophylaxis in patients with predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Ned. Tijdschr. Geneeskd., 152, 2008, 685.
5. Besselink, M.G., van Santvoort, H.C., Buskens, E., Boermeester, M.A., van Goor, H., Timmerman, H.M., Nieuwenhuijs, V.B., Bollen, T.L., van Ramshorst, B., Witteman, B.J., Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008), 651–659.
6. Boumis, E., Capone, A., Galati, V., Venditti, C., Petrosillo, N., Probiotics and infective endocarditis in patients with hereditary hemorrhagic telangiectasia: a clinical case and a review of the literature. BMC Infect. Dis., 18(1), 2018, 65.
7. Braat, H., de Jong, E.C., van den Brande, J.M., Kapsenberg, M.L., Peppelenbosch, M.P., van Tol, E.A., van Deventer, S.J., Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. J. Mol. Med. 82 (2004), 197–205.
8. Brown, A.C., Valiere, A., Probiotics and medical nutrition therapy. Nutr. Clin. Care: Off. Publ. Tufts Univ., 7, 2004, 56.
9. Carter, G.M., Esmaeili, A., Shah, H., Indyk, D., Johnson, M., Andreae, M., Sacks, H.S., Probiotics in human immunodeficiency virus infection: a systematic review and evidence synthesis of benefits and risks. Open Forum Infect Dis, 3(4), 2016, ofw164.
10. Cassone, M., Serra, P., Mondello, F., Girolamo, A., Scafetti, S., Pistella, E., Venditti, M., Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J. Clin. Microbiol. 41 (2003), 5340–5343.
11. Ciernikova, S., Mego, M., Semanova, M., Wachsmannova, L., Adamcikova, Z., Stevurkova, V., Drgona, L., Zajac, V., Probiotic survey in cancer patients treated in the outpatient department in a comprehensive cancer center. Integr. Cancer Ther. 16 (2017), 188–195.
12. Cohen, R., Martin, E., de La Rocque, F., Thollot, F., Pecquet, S., Werner, A., Boucherat, M., Varon, E., Bingen, E., Levy, C., Probiotics and prebiotics in preventing episodes of acute otitis media in high-risk children: a randomized, double-blind, placebo-controlled study. Pediatr. Infect. Dis. J. 32 (2013), 810–814.
13. Conen, A., Zimmerer, S., Trampuz, A., Frei, R., Battegay, M., Elzi, L., A pain in the neck: probiotics for ulcerative colitis. Ann. Intern. Med. 151 (2009), 895–897.
14. Cook, D.J., Johnstone, J., Marshall, J.C., Lauzier, F., Thabane, L., Mehta, S., Dodek, P.M., McIntyre, L., Pagliarello, J., Henderson, W., Probiotics: prevention of severe pneumonia and endotracheal colonization trial—PROSPECT: a pilot trial. Trials, 17, 2016, 377.
15. Costa, R.L., Moreira, J., Lorenzo, A., Lamas, C.C., Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series. BMC Complement Altern. Med., 18(1), 2018, 329.
16. Czaja, C.A., Stapleton, A.E., Yarova-Yarovaya, Y., Stamm, W.E., Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect. Dis. Obstet. Gynecol., 2007, 2007.
17. de Araujo, G.V., de Oliveira Junior, M.H., Peixoto, D.M., Sarinho, E.S.C., Probiotics for the treatment of upper and lower respiratory-tract infections in children: systematic review based on randomized clinical trials. J. Pediatr. 91 (2015), 413–427.
18. Dessart, S., Steenson, L., High frequency intergeneric and intrageneric conjugal transfer of drug resistance plasmids in leuconostoc mesenteroides ssp. cremoris1. J. Dairy Sci. 74 (1991), 2912–2919.
19. Di Cerbo, A., Palmieri, B., Aponte, M., Morales-Medina, J.C., Iannitti, T., Mechanisms and therapeutic effectiveness of lactobacilli. J. Clin. Pathol. 69 (2016), 187–203.
20. Di Cerbo, A., Palmieri, B., Aponte, M., Morales-Medina, J.C., Iannitti, T., Mechanisms and therapeutic effectiveness of lactobacilli. J. Clin. Pathol. 69 (2016), 187–203.
21. Drakes, M., Blanchard, T., Czinn, S., Bacterial probiotic modulation of dendritic cells. Infect. Immun. 72 (2004), 3299–3309.
22. Durchschein, F., Petritsch, W., Hammer, H.F., Diet therapy for inflammatory bowel diseases: the established and the new. World J. Gastroenterol., 22, 2016, 2179.
23. Eskesen, D., Jespersen, L., Michelsen, B., Whorwell, P.J., Müller-Lissner, S., Morberg, C.M., Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br. J. Nutr. 114 (2015), 1638–1646.
24. Evans, M., Salewski, R.P., Christman, M.C., Girard, S.-A., Tompkins, T.A., Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial. Br. J. Nutr. 116 (2016), 94–103.
25. Fradiani, P.A., Petrucca, A., Ascenzioni, F., Di Nucci, G., Teggi, A., Bilancini, S., Cipriani, P., Endocarditis caused by Lactobacillus jensenii in an immunocompetent patient. J. Med. Microbiol. 59 (2010), 607–609.
26. Freedman, S.B., Williamson-Urquhart, S., Farion, K.J., Gouin, S., Willan, A.R., Poonai, N., Hurley, K., Sherman, P.M., Finkelstein, Y., Lee, B.E., Multicenter trial of a combination probiotic for children with gastroenteritis. N. Engl. J. Med. 379 (2018), 2015–2026.
27. Fukuda, S., Toh, H., Taylor, T.D., Ohno, H., Hattori, M., Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microb. 3 (2012), 449–454.
28. Gevers, D., Danielsen, M., Huys, G., Swings, J., Molecular characterization of tet (M) genes in Lactobacillus isolates from different types of fermented dry sausage. Appl. Environ. Microbiol. 69 (2003), 1270–1275.
29. Goldenberg, J.Z., Ma, S.S., Saxton, J.D., Martzen, M.R., Vandvik, P.O., Thorlund, K., Guyatt, G.H., Johnston, B.C., Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children. Cochrane Database Syst. Rev., 2013, 10.1002/14651858.CD006095.pub4.
30. Goldenberg, J.K., Lytvyn, L., Steurich, J., Parkin, P., Sanjay, M., Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev., 2015, 10.1002/14651858.CD004827.pub4.
31. Goldenberg, J.Z., Yap, C., Lytvyn, L., Lo, C.K., Beardsely, J., Mertz, D., Johnston, B.C., Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst. Rev., 2017, 10.1002/14651858.
32. Garcia-Mantrana, I., Collado, M.C., Obesity and overweight: impact on maternal and milk microbiome and their role for infant health and nutrition. Mol. Nutr. Food Res. 60 (2016), 1865–1875.
33. Gratz, S.W., Mykkanen, H., El-Nezami, H.S., Probiotics and gut health: a special focus on liver diseases. World J. Gastroenterol.: WJG, 16, 2010, 403.
34. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol., 11, 2014, 506.
35. Honeycutt, T.C., El Khashab, M., Wardrop, R.M., McNeal-Trice, K., Honeycutt, A.L., Christy, C.G., Mistry, K., Harris, B.D., Meliones, J.N., Kocis, K.C., Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr. Crit. Care Med. 8 (2007), 452–458.
36. Ilavenil, S., Park, H.S., Vijayakumar, M., Valan Arasu, M., Kim, D.H., Ravikumar, S., Choi, K.C., Probiotic potential of Lactobacillus strains with antifungal activity isolated from animal manure. Sci. World J., 2015, 2015.
37. Jain, P.K., McNaught, C.E., Anderson, A.D., MacFie, J., Mitchell, C.J., Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin. Nutr. 23 (2004), 467–475.
38. Johnston, B.C., Goldenberg, J.Z., Vandvik, P.O., Sun, X., Guyatt, G.H., Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev., 11, 2011.
39. Johnston, B.C., Ma, S.S., Goldenberg, J.Z., Thorlund, K., Vandvik, P.O., Loeb, M., Guyatt, G.H., Probiotics for the prevention of Clostridium difficile–associated diarrhea: a systematic review and meta-analysis. Ann. Intern. Med. 157 (2012), 878–888.
40. Joint FAO/WHO Working Group Report, on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada. 2002 April 30 and May 1 http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf. (Accessed 15 April 2019)
41. Jose, N.M., Bunt, C.R., Hussain, M.A., Comparison of microbiological and probiotic characteristics of lactobacilli isolates from dairy food products and animal rumen contents. Microorganisms 3 (2015), 198–212.
42. Kara, I., Yıldırım, F., Özgen, Ö., Erganiş, S., Aydoğdu, M., Dizbay, M., Gürsel, G., Kalkanci, A., Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient. J. Mycol. Med. 28:1 (2018), 218–221.
43. Karpa, K.D., Probiotics for Clostridium difficile Diarrhea: Putting it into Perspective. 2007, SAGE Publications Sage CA, Los Angeles, CA.
44. Kochan, P., Chmielarczyk, A., Szymaniak, L., Brykczynski, M., Galant, K., Zych, A., Pakosz, K., Giedrys-Kalemba, S., Lenouvel, E., Heczko, P., Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient—is the time right to revise probiotic safety guidelines?. Clin. Microbiol. Infect. 17 (2011), 1589–1592.
45. Kumpu, M., Kekkonen, R., Kautiainen, H., Järvenpää, S., Kristo, A., Huovinen, P., Pitkäranta, A., Korpela, R., Hatakka, K., Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial. Eur. J. Clin. Nutr., 66, 2012, 1020.
46. Lahtinen, S., Davis, E., Ouwehand, A., Lactobacillus species causing obesity in humans: where is the evidence?. Benef. Microbes 3 (2012), 171–174.
47. Land, M.H., Rouster-Stevens, K., Woods, C.R., Cannon, M.L., Cnota, J., Shetty, A.K., Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115 (2005), 178–181.
48. Lee, S.K., Kim, H.J., Chi, S.G., Saccharomyces boulardii reduced intestinal inflammation in mice model of 2, 4, 6-trinitrobencene sulfonic acid induced colitis: based on microarray. Korean J. Gastroenterol. 55 (2010), 33–45.
49. Lemas, D.J., Yee, S., Cacho, N., Miller, D., Cardel, M., Gurka, M., Janicke, D., Shenkman, E., Exploring the contribution of maternal antibiotics and breastfeeding to development of the infant microbiome and pediatric obesity. Seminars in Fetal and Neonatal Medicine, 2016, Elsevier, 406–409.
50. Lin, C.-F., Fung, Z.-F., Wu, C.-L., Chung, T.-C., Molecular characterization of a plasmid-borne (pTC82) chloramphenicol resistance determinant (cat-TC) fromLactobacillus reuteriG4. Plasmid 36 (1996), 116–124.
51. Łukasik, J., Szajewska, H., Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial. BMJ open, 8, 2018, e021214.
52. Mackay, A.D., Taylor, M.B., Kibbler, C.C., Hamilton‐Miller, J.M., Lactobacillus endocarditis caused by a probiotic organism. Clin. Microbiol. Infect. 5 (1999), 290–292.
53. Magro, D.O., de Oliveira, L.M.R., Bernasconi, I., de Souza Ruela, M., Credidio, L., Barcelos, I.K., Leal, R.F., Ayrizono, M.d.L.S., Fagundes, J.J., de B Teixeira, L., Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation. Nutr. J., 13, 2014, 75.
54. Mañé, J., Lorén, V., Pedrosa, E., Ojanguren, I., Xaus, J., Cabré, E., Domènech, E., Gassull, M.A., Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS‐induced colitis in mice. Inflamm. Bowel Dis. 15 (2009), 1155–1163.
55. Mantaring, J., Benyacoub, J., Destura, R., Pecquet, S., Vidal, K., Volger, S., Guinto, V., Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines. BMC Pregnancy Childbirth, 18, 2018, 193.
56. Mendes, H.B., Plaza-Diaz, J., Bomfim, M.R.Q., Hernandez, A.G., Monteiro-Neto, V., Technology prospecting of infant stool as a source of novel probiotic products. Revista GEINTEC-Gestão, Inovação e Tecnologias. 8 (2018), 4240–4249.
57. Mileon-Etuk, O.B., Are the use of probiotics an effective treatment for relieving symptoms of depression in adults?. 2018.
58. Morelli, L., Sarra, P., Bottazzi, V., In vivo transfer of pAMβ1 from Lactobacillus reuteri to Enterococcus faecalis. J. Appl. Microbiol. 65 (1988), 371–375.
59. Mueller, N.T., Mao, G., Bennet, W., Hourigan, S., Dominguez-Bello, M.G., Appel, L.J., Wang, X., Does vaginal delivery mitigate or strengthen the intergenerational association of overweight and obesity? Findings from the Boston Birth Cohort. Int. J. Obes., 41, 2017, 497.
60. Munakata, S., Arakawa, C., Kohira, R., Fujita, Y., Fuchigami, T., Mugishima, H., A case of D-lactic acid encephalopathy associated with use of probiotics. Brain Dev. 32 (2010), 691–694.
61. National Center for complementary and Integrative Health. Probiotics: in Depth. https://nccih.nih.gov/health/probiotics/introduction.html (accessed April 15, 2019).
62. Ng, Q.X., Soh, A.Y.S., Venkatanarayanan, N., Ho, C.Y.X., Lim, D.Y., Yeo, W.S., A systematic review of the effect of probiotic supplementation on schizophrenia symptoms. Neuropsychobiology, 2019, 10.1159/000498862.
63. Ohishi, A., Takahashi, S., Ito, Y., Ohishi, Y., Tsukamoto, K., Nanba, Y., Ito, N., Kakiuchi, S., Saitoh, A., Morotomi, M., Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J. Pediatr. 156 (2010), 679–681.
64. Presterl, E., Kneifel, W., Mayer, H.K., Zehetgruber, M., Makristathis, A., Graninger, W., Endocarditis by Lactobacillus rhamnosus due to yogurt ingestion?. Scand. J. Infect. Dis. 33 (2001), 710–714.
65. Rautio, M., Jousimies-Somer, H., Kauma, H., Pietarinen, I., Saxelin, M., Tynkkynen, S., Koskela, M., Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin. Infect. Dis. 28 (1999), 1159–1160.
66. Recio, R., Chaves, F., Reyes, C.A., Orellana, M.Á., Infective endocarditis due to Lactobacillus rhamnosus: risks of probiotic consumption in a patient with structural heart disease. Enfermedades Infecc. Microbiol. Clínica 35:9 (2017), 609–610.
67. Redman, M., Ward, E., Phillips, R., The efficacy and safety of probiotics in people with cancer: a systematic review. Ann. Oncol. 25 (2014), 1919–1929.
68. Reid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R., Bruce, A.W., Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 35 (2003), 131–134.
69. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
70. Rijkers, G.T., De Vos, W.M., Brummer, R.-J., Morelli, L., Corthier, G., Marteau, P., Health benefits and health claims of probiotics: bridging science and marketing. Br. J. Nutr. 106 (2011), 1291–1296.
71. Robin, F., Paillard, C., Marchandin, H., Demeocq, F., Bonnet, R., Hennequin, C., Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in a child undergoing allogeneic hematopoietic stem cell transplantation. J. Clin. Microbiol. 48 (2010), 4317–4319.
72. Rogozińska, E., Chamillard, M., Hitman, G.A., Khan, K.S., Thangaratinam, S., Nutritional manipulation for the primary prevention of gestational diabetes mellitus: a meta-analysis of randomised studies. PLoS One, 10, 2015, e0115526.
73. Rowland, I.R., Capurso, L., Collins, K., Cummings, J., Delzenne, N., Goulet, O., Guarner, F., Marteau, P., Meier, R., Current Level of Consensus on Probiotic Science-Report of an Expert meeting-London, 23 November 2009., 2010, Report of an expert meeting-London 23 November 2009.
74. Salari, P., Nikfar, S., Abdollahi, M., A meta-analysis and systematic review on the effect of probiotics in acute diarrhea. Inflamm. Allergy - Drug Targets 11 (2012), 3–14.
75. Salek-Maghsoudi, A., Hassani, S., Momtaz, S., Shadboorestan, A., Ganjali, M.R., Ghahremani, M.H., Hosseini, R., Norouzi, P., Abdollahi, M., Biochemical and molecular evidence on the role of vaspin in early detection of the insulin resistance in a rat model of high-fat diet and use of diazinon. Toxicol 411 (2018), 1–14.
76. Salminen, S., Van Loveren, H., Probiotics and prebiotics: health claim substantiation. Microb. Ecol. Health Dis., 23, 2012, 18568.
77. Salminen, M.K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V., Järvinen, A., Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin. Infect. Dis. 35 (2002), 1155–1160.
78. Salminen, M.K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., Järvinen, A., Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin. Infect. Dis. 38 (2004), 62–69.
79. Santino, I., Alari, A., Bono, S., Teti, E., Marangi, M., Bernardini, A., Magrini, L., Di Somma, S., Teggi, A., Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum. Int. J. Immunopathol. Pharmacol. 27 (2014), 143–146.
80. Schnadower, D., Tarr, P.I., Casper, T.C., Gorelick, M.H., Dean, M.J., O'Connell, K.J., Mahajan, P., Chun, T.H., Bhatt, S.R., Roskind, C.G., Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol. BMJ open, 7, 2017, e018115.
81. Schnadower, D., Tarr, P.I., Casper, T.C., Gorelick, M.H., Dean, J.M., O'connell, K.J., Mahajan, P., Levine, A.C., Bhatt, S.R., Roskind, C.G., Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children. N. Engl. J. Med. 379 (2019), 2002–2014.
82. Schwenger, E.M., Tejani, A.M., Loewen, P.S., Probiotics for Preventing Urinary Tract Infections in Adults and Children. 2015, The Cochrane Library.
83. Sharma, M., Shukla, G., Metabiotics: one step ahead of probiotics; an insight into mechanisms involved in anticancerous effect in colorectal cancer. Front. Microbiol., 7, 2016, 1940.
84. Sherid, M., Samo, S., Sulaiman, S., Husein, H., Sifuentes, H., Sridhar, S., Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literature. BMC Gastroenterol., 16, 2016, 138.
85. Simakachorn, N., Bibiloni, R., Yimyaem, P., Tongpenyai, Y., Varavithaya, W., Grathwohl, D., Reuteler, G., Maire, J.-C., Blum, S., Steenhout, P., Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre-and probiotics in critically ill children. J. Pediatr. Gastroenterol. Nutr. 53 (2011), 174–181.
86. Siu, S., Examination of Probiotics Labeling: Analyzing the Accuracy of Labeling on Probiotic Products. 2018.
87. Skillman, H.E., Wischmeyer, P.E., Nutrition therapy in critically ill infants and children. JPEN - J. Parenter. Enter. Nutr. 32 (2008), 520–534.
88. Snijder, M.B., Van der Heijden, A.A., Van Dam, R.M., Stehouwer, C.D., Hiddink, G.J., Nijpels, G., Heine, R.J., Bouter, L.M., Dekker, J.M., Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study. Am. J. Clin. Nutr. 85 (2007), 989–995.
89. Snydman, D.R., The safety of probiotics. Clin. Infect. Dis. 46 (2008), S104–S111.
90. Soderborg, T.K., Borengasser, S.J., Barbour, L.A., Friedman, J.E., Microbial transmission from mothers with obesity or diabetes to infants: an innovative opportunity to interrupt a vicious cycle. Diabetologia 59 (2016), 895–906.
91. Søndenaa, K., Høiby, E.A., Digranes, A., Jureen, R., Lactobacillus rhamnosus septicaemia in a patient with a graft in the inferior vena cava. Scand. J. Infect. Dis. 34 (2002), 135–136.
92. Splichalova, A., Jenistova, V., Splichalova, Z., Splichal, I., Colonization of preterm gnotobiotic piglets with probiotic Lactobacillus rhamnosus GG and its interference with Salmonella Typhimurium. Clin. Exp. Immunol. 195:3 (2019), 381–394.
93. Stapleton, A.E., Au-Yeung, M., Hooton, T.M., Fredricks, D.N., Roberts, P.L., Czaja, C.A., Yarova-Yarovaya, Y., Fiedler, T., Cox, M., Stamm, W.E., Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin. Infect. Dis. 52 (2011), 1212–1217.
94. Stroupe, C., Pendly, J., Isang, E., Helms, B., Persistent bacteremia secondary to delayed identification of Lactobacillus in the setting of mitral valve endocarditis. IDCases 10 (2017), 132–134.
95. Tannock, G.W., Luchansky, J.B., Miller, L., Connell, H., Thode-Andersen, S., Mercer, A.A., Klaenhammer, T.R., Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63. Plasmid 31 (1994), 60–71.
96. Tano, K., Håkansson, E.G., Holm, S.E., Hellström, S., A nasal spray with alpha-haemolytic streptococci as long term prophylaxis against recurrent otitis media. Int. J. Pediatr. Otorhinolaryngol. 62 (2002), 17–23.
97. Taylor, B.L., Woodfall, G.E., Sheedy, K.E., O'Riley, M.L., Rainbow, K.A., Bramwell, E.L., Kellow, N.J., Effect of probiotics on metabolic outcomes in pregnant women with gestational diabetes: a systematic review and meta-analysis of randomized controlled trials. Nutrients, 2017, 10.3390/nu9050461.
98. The European Food Safety Authority (EFSA), Health Benefits and Health Claims of Probiotics: Bridging Science and Marketing. 2012 (accessed April 15, 2019) https://effca.org/_library/_files/Health-benefits-and-health-claims-of-probiotics-bridging-science-and-marketing-JAN2012.pdf.
99. Tommasi, C., Equitani, F., Masala, M., Ballardini, M., Favaro, M., Meledandri, M., Fontana, C., Narciso, P., Nicastri, E., Diagnostic difficulties of Lactobacillus casei bacteraemia in immunocompetent patients: a case report. J. Med. Case Rep., 2, 2008, 315.
100. Trautmann, M., Synowzik, I., Nadji-Ohl, M., Von Voigt, T., Reiter, W., Fungamie durch Saccharomyces cerevisiae var. boulardii. Chemother. J., 17, 2008, 57.
101. Uberos, J., Aguilera-Rodríguez, E., Jerez-Calero, A., Molina-Oya, M., Molina-Carballo, A., Narbona-López, E., Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants. Br. J. Nutr. 117 (2017), 994–1000.
102. Vaarala, O., Immunological effects of probiotics with special reference to lactobacilli. Clin. Exp. Allergy 33 (2003), 1634–1640.
103. Vahabnezhad, E., Mochon, A.B., Wozniak, L.J., Ziring, D.A., Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J. Clin. Gastroenterol. 47 (2013), 437–439.
104. Vandenplas, Y., Huys, G., Daube, G., Probiotics: an update. J. Pediatr. 91:1 (2015), 6–21.
105. Veckman, V., Miettinen, M., Pirhonen, J., Sirén, J., Matikainen, S., Julkunen, I., Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1‐type cytokines and chemokines in human monocyte‐derived dendritic cells. J. Leukoc. Biol. 75 (2004), 764–771.
106. Watson, R.R., Preedy, V.R., Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion. 2015, Academic Press.
107. Wong, V.W., Won, G.L., Chim, A.M., Chu, W.C., Yeung, D.K., Li, K.C., Chan, H.L., Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann. Hepatol. 12:2 (2013), 256–262.
108. Wong, A., Ngu, D.Y.S., Dan, L.A., Ooi, A., Lim, R.L.H., Detection of antibiotic resistance in probiotics of dietary supplements. Nutr. J., 2015, 10.1186/s12937-015-0084-2.
109. Zein, E., Karaa, S., Chemaly, A., Saidi, I., Daou-Chahine, W., Rohban, R., Lactobacillus Rhamnosus Septicemia in a Diabetic Patient Associated with Probiotic Use: a Case Report., 2008, Annales de biologie clinique, 195–198.
110. Zheng, M., Zhang, R., Tian, X., Zhou, X., Pan, X., Wong, A., Assessing the risk of probiotic dietary supplements in the context of antibiotic resistance. Microbiol., 2017, 10.3389/fmicb.2017.00908.